Finance

Lists
Why is EVMN down 3.20%?
Dive Deeper
EVMN:NYSE
Evommune Inc
$ 6.05
-3.20%
(-0.20) 1D
$ 5.99
-0.99% (-0.060)
After hours
Closed: 10-р сарын 12, 16:00:02 (GMT-4)  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for EVMN...
Open
$ 6.09
High
$ 6.22
Low
$ 6.04
Mkt. cap
219.57 сая
Avg. vol.
894.64 мян
Volume
384.15 мян
52-wk high
$ 33.20
52-wk low
$ 6.02
EPS
-$ 2.89
Shares outstanding
36.29 сая
No. of employees
48
Open
$ 6.09
High
$ 6.22
Low
$ 6.04
Mkt. cap
219.57 сая
Avg. vol.
894.64 мян
Volume
384.15 мян
52-wk high
$ 33.20
52-wk low
$ 6.02
EPS
-$ 2.89
Shares outstanding
36.29 сая
No. of employees
48
News stories
From web sources and news partners
About Evommune Inc
CEO-
Employees48
Founded2020
HeadquartersPalo Alto, Калифорни, Америкийн Нэгдсэн Улс
Sector-
Analyst ratings
Based on 13 analysts giving stock ratings to EVMN in the past 3 months
Strong buy
Buy
10
Hold
3
Sell
0
12-month forecast
Based on 13 Wall Street analysts offering 12 month price targets for EVMN in the last 3 months.
Highest
Current $ 6.05
$ 30.00 (+395.87%)
Average
$ 22.40 (+270.25%)
Lowest
$ 8.00 (+32.23%)
Analyst
Recommendation
Action
Price target
Projected
Date
Alice Nettleton
UBS
Hold
Initiated
$ 8.00
+32.2%
10/12/2026
Unknown Analyst
UBS
Hold
Initiated
$ 8.00
+32.2%
10/11/2026
Mitchell Kapoor
H.C. Wainwright
Hold
Reiterated
-
-
10/05/2026
Prakhar Agrawal
Cantor Fitzgerald
Buy
Maintained
-
-
09/17/2026
Kaveri Pohlman
Clear Street
Buy
Maintained
$ 23.00
+280.2%
09/09/2026
Alex Thompson CFA
Stifel Nicolaus
Buy
Maintained
$ 30.00
+395.9%
09/09/2026
Serge Belanger
Needham
Buy
Maintained
$ 28.00
+362.8%
09/09/2026
Thomas Smith
Leerink Partners
Buy
Reiterated
$ 22.00
+263.6%
09/10/2026
Martin Auster
Raymond James
Buy
Maintained
$ 18.00
+197.5%
09/09/2026
Kostas Biliouris
Oppenheimer
Buy
Reiterated
$ 26.00
+329.8%
09/09/2026
Brian Abrahams
RBC Capital
Buy
Maintained
$ 21.00
+247.1%
09/08/2026
Matt Phipps
William Blair
Hold
Maintained
-
-
09/09/2026
Gavin Clark-Gartner
Evercore ISI
Buy
Maintained
$ 22.00
+263.6%
08/10/2026
Judah Frommer
Morgan Stanley
Buy
Reiterated
$ 26.00
+329.8%
08/10/2026
Last report
2026 оны 8-р сарын 6
Fiscal period
Q2 2026
-$ 0.89 / -$ 0.67
-32.84%miss
Revenue / Est. (USD)
- / 1.14 сая
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
10.00 сая
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
19.64 сая
20.40 сая
17.32 сая
26.41 сая
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.69 сая
9.31 сая
6.64 сая
8.48 сая
Operating expense
23.33 сая
29.72 сая
23.95 сая
34.90 сая
Total operating expenses
23.33 сая
29.72 сая
23.95 сая
34.90 сая
Operating income
-13.33 сая
-29.72 сая
-23.95 сая
-34.90 сая
Other non operating income
-9.00 мян
-
-4.00 мян
-2.00 мян
EBT including unusual items
-12.48 сая
-28.27 сая
-21.67 сая
-32.25 сая
EBT excluding unusual items
-12.48 сая
-28.27 сая
-21.67 сая
-32.25 сая
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-12.48 сая
-28.27 сая
-21.67 сая
-32.25 сая
Net profit margin
-124.75%
-
-
-
Earnings per share
-8.07
-1.43
-0.64
-0.89
Interest and investment income
862.00 мян
1.44 сая
2.28 сая
2.65 сая
Interest expense
-
-
-
-
Net interest expenses
862.00 мян
1.44 сая
2.28 сая
2.65 сая
Depreciation and amortization charges
-
-
-
-
EBITDA
-13.02 сая
-29.39 сая
-23.60 сая
-34.34 сая
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google аппс